YP
GILD icon

YANKCOM Partnership’s Gilead Sciences GILD Stock Holding History

YANKCOM Partnership’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.1K Hold
270
– – 0.01% 207
2026
Q1 		$37.6K Hold
270
– – 0.02% 201
2025
Q4 		$33.1K Hold
270
– – 0.01% 210
2025
Q3 		$30K Sell
270
-24
-8% -$2.73K 0.01% 201
2025
Q2 		$32.6K Hold
294
– – 0.02% 191
2025
Q1 		$32.9K Sell
294
-7
-2% -$722 0.02% 188
2024
Q4 		$27.8K Buy
+301
New +$27.1K 0.01% 195

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

YANKCOM Partnership's GILD Position: Q2 2026 in Review

YANKCOM Partnership held its Gilead Sciences (GILD) position steady in Q2 2026 at 270 shares worth $34.1K. The position accounts for 0.01% of the portfolio, ranked #207.

YANKCOM Partnership first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $37.6K in Q1 2026. 1,368 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • YANKCOM Partnership held 270 shares of Gilead Sciences worth $34.1K as of Q2 2026.
  • YANKCOM Partnership left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.01% of YANKCOM Partnership's portfolio in Q2 2026, its #207 holding.
  • YANKCOM Partnership first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • YANKCOM Partnership's Gilead Sciences position peaked at $37.6K in Q1 2026.
  • 1,368 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on YANKCOM Partnership's 13F filing for Q2 2026, filed 21 Jul 2026.